N@N

SONOMAX REPORTS 2010 RESULTS

_{//health-fitness.news-articles.net/content/2011/04/21/sonomax-reports-2010-results.html}
^{Published in Health and Fitness on Thursday, April 21st 2011 at 16:50 GMT by Market Wire}  

MONTREAL, April 21 /CNW Telbec/ - Sonomax Technologies Inc. ("Sonomax" or the "Company") (TSXV: SHH) today disclosed its results for the year ended December 31, 2010.

As Sonomax moves closer to meeting its objective of becoming an R&D licensing company, 2010 highlights were:

• Raised gross proceeds of $2,034,483 by way of exercising of warrants by holders thereof.
  
  
• Reduced outstanding convertible debt to $706,200 from $1,177,000.
  
  
• Plan of arrangement on March 3, 2010 resulted in a net inflow of cash (before transaction costs) of $1,566,000.
  
  
• Decrease in net revenue to $642,766 in 2010 from $736,374 in 2009.
  
  
• Gross profit was $43,316 in 2010 compared to a loss of $181,174 in 2009.
  
  
• Increase in operating expenses to $4,192,743 compared to $3,255,273 in 2009.

Full financial statements can be found at: [ www.sedar.com ]

About Sonomax Technologies Inc.

Sonomax is a leader in the research, development and licensing of in-ear technologies. With over 50 patents worldwide, Sonomax pioneering innovation includes instant custom-fitting earpieces that deliver the most comfortable protective and sound enhancing experience in the world as well as software driven solutions for validating earpiece performance. The latest V-4 "custom-fit by Sonomax" System offers our OEM, ODM and aftermarket clients a broader range of opportunities in customized earpieces for the Consumer, Industrial, Military and Medical markets.

([ www.sonomax.com ])

This news release contains certain forward-looking statements that reflect the current views and/or expectations of Sonomax Technologies Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.